There’s no single fixed duration for meloxicam. The FDA-approved guidance is to use the lowest effective dose for the shortest time that meets your treatment goals. In practice, that could mean a week or two for a flare-up, or months to years for a chronic condition like osteoarthritis or rheumatoid arthritis. The right duration depends on what you’re treating, how well it’s working, and what risks accumulate over time.
How Quickly Meloxicam Works
Meloxicam has a long half-life of 15 to 20 hours, which is why it’s taken just once a day. But that same slow metabolism means it builds up gradually in your system. With daily dosing, it reaches its full steady-state concentration by day five. So if you start taking meloxicam and don’t feel much relief on day one or two, that’s expected. Give it about five days of consistent use before judging whether it’s helping.
Short-Term Use for Acute Inflammation
For injuries, post-surgical swelling, or temporary inflammatory flares, meloxicam is typically used for days to a few weeks. The goal is straightforward: reduce pain and inflammation while the underlying issue heals, then stop. Over-the-counter NSAIDs carry a general recommendation to avoid use beyond 10 days without medical guidance, and the same principle applies to prescription-strength meloxicam. If your inflammation is from something that will resolve on its own, there’s rarely a reason to stay on meloxicam longer than two to three weeks.
Long-Term Use for Chronic Conditions
Osteoarthritis and rheumatoid arthritis are the two main conditions meloxicam is prescribed for, and neither goes away. The standard dose for both is 7.5 mg once daily, with the option to increase to 15 mg (the maximum) if needed. Many people with these conditions take meloxicam for months or even years because the inflammation is ongoing and the medication provides meaningful relief.
This is where the balance shifts. Long-term use is sometimes necessary, but it comes with escalating risks that need active management. Your prescriber should periodically reassess whether you still need the medication, whether the dose can be lowered, and whether the benefits continue to outweigh the downsides.
Risks That Increase With Duration
The longer you take meloxicam, the more certain risks climb. The FDA places a boxed warning (its most serious alert) on all NSAIDs, including meloxicam, for two categories of harm.
Cardiovascular risk. NSAIDs increase the chance of heart attack and stroke, and this risk can appear early in treatment but grows with continued use. People with existing heart disease or risk factors are more vulnerable, but the warning applies to everyone.
Gastrointestinal damage. Stomach ulcers, serious bleeding, and perforation of the stomach or intestinal wall are all possible. The numbers are concrete: roughly 1% of patients treated for three to six months develop upper GI ulcers or significant bleeding. That figure rises to 2 to 4% after a full year of use. These events can happen without warning symptoms.
Kidney effects. Meloxicam reduces blood flow to the kidneys, which can cause fluid retention or, over time, declining kidney function. This is especially relevant for older adults and anyone already taking medications that affect the kidneys, like certain blood pressure drugs.
What Monitoring Looks Like on Extended Use
If you’re taking meloxicam beyond a few weeks, your provider should be checking certain things at regular intervals. Before starting, baseline bloodwork typically includes kidney function, a complete blood count, and blood pressure. Within two weeks of starting or changing the dose, kidney function and blood counts are usually rechecked. Around four weeks in, hemoglobin may be tested if you’re at higher risk for GI bleeding.
Once you’re stable on a long-term dose, periodic monitoring continues. Kidney function, blood counts, and liver function tests are the main ones. This isn’t optional caution. It’s how problems like slow GI bleeding or early kidney changes get caught before they become serious. If your provider hasn’t ordered any lab work in a while, it’s worth asking about it.
Factors That Shorten the Safe Window
Several things can make long-term meloxicam riskier, which effectively means you should aim for a shorter duration or more frequent check-ins:
- Age over 65: Older adults face higher rates of GI bleeding, kidney problems, and cardiovascular events on NSAIDs.
- History of stomach ulcers or GI bleeding: Past episodes significantly raise the chance of recurrence.
- Heart disease or stroke history: The cardiovascular risk of NSAIDs is amplified in people who already have vascular disease.
- Kidney impairment: Even mild kidney disease makes NSAID-related kidney damage more likely.
- Alcohol use: Drinking while on meloxicam compounds the risk of stomach bleeding. Avoiding alcohol entirely during treatment is the safest approach. If you do drink, waiting at least 24 to 48 hours after your last dose reduces the overlap.
Practical Takeaways on Duration
For a short-term inflammatory problem, aim for the fewest days that get you through the worst of it. A week or two is common. For chronic arthritis, ongoing use may be appropriate, but it should be the result of a deliberate decision rather than autopilot refilling. The 7.5 mg starting dose is enough for many people, and bumping to 15 mg should only happen if the lower dose genuinely isn’t sufficient.
Every few months on meloxicam, it’s worth doing a simple mental check: is the inflammation still active? Is the medication still providing clear benefit? Could a lower dose work? Are there non-drug strategies (physical therapy, weight management, topical treatments) that could reduce how much you rely on it? The goal isn’t to avoid meloxicam entirely. It’s to make sure you’re not taking it longer or at higher doses than your body actually needs.